Vivos Therapeutics (NASDAQ: VVOS) , a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep related ...
U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining around 100 500 points on Thursday. The Dow ...
U.S. stocks traded higher midway through trading, with the Dow Jones index jumping more than 500 points on Thursday. The Dow ...
Vivos Therapeutics shares dropped Thursday after the company said it is offering 1.4 million common shares at $3.15 per share in a registered direct offering. Shares were down 27% to $3.03 in recent ...
Vivos Therapeutics shares are trading lower by 25% Thursday morning. The company announced a $4.3 million registered offering ...
Dogecoin (DOGE), the memecoin known for its Shiba Inu mascot, has witnessed a significant increase in network activity. Over ...
Long AXP: strong momentum and upward price targets indicate continued bullish run toward $300 ...
The House passed 14 bipartisan health bills. Here's a rundown on the legislation from the office of Rep. Cathy McMorris ...
U.S. stocks traded higher this morning, with the Nasdaq Composite surging more than 400 points on Thursday. Following the ...
The gross proceeds to the Company from the offering are expected to be approximately $4.3 million, before deducting the placement agent's fees and other offering expenses payable by the Company. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback